DeepIntent obtains a patent for DeepIntent Outcomes™ technology, which optimizes advertising campaigns to increase audience quality and script augmentation using real clinical data
NEW YORK, July 12, 2021 /PRNewswire/ — DeepIntentthe leading independent healthcare marketing technology company purposely created to influence patient health and business outcomes, announced that it had been awarded a patent for DeepIntent Results of the United States Patent and Trademark Office. This makes DeepIntent the only demand-side platform (DSP) using patented technology to link real-world clinical data with impression data to measure and optimize live campaigns based on the quality of the audience (QA) and script performance metrics.
Using DeepIntent’s patented technology, healthcare marketers can algorithmically measure and optimize live campaigns towards real business outcomes, such as QA and script elevation (TRx, NRx, NBRx) , based on prescribing behaviors and verified exposures against the fastest, most comprehensive clinical outcomes in the industry. and pharmaceutical datasets.
“DeepIntent Outcomes represents the culmination of five years of healthcare marketing innovation to unify campaign planning, activation, measurement and optimization,” said DeepIntent CEO. Chris Paquette. “Aided by the most comprehensive, timely and actionable datasets in the industry, DeepIntent Outcomes enables marketers to go beyond clicks and impressions to focus on the metrics that matter. Daily data refreshes give marketers the confidence of knowing that their campaigns are optimized for real-world business performance, producing better patient outcomes.”
DeepIntent results, launched earlier this year, brings significant and differentiated features and capabilities to the market. These include measuring how key campaign metrics, such as audience, media, and messaging, drive script lift. Every aspect of campaign performance is considered and automatically optimized by privacy-friendly machine learning algorithms that select the optimal creative, audience, frequency, context, and locations to serve ads. Optimization algorithms also uncover unexpected insights in real time, resulting in unprecedented cost reduction and return on investment.
“DeepIntent is a forward-thinking company that shares our mission to ensure patients receive the right treatment at the right time. By leveraging Komodo Health’s comprehensive real-world database within its platform and DeepIntent’s DSP, marketers can trace the links between ad campaigns and patient outcomes,” mentioned Lauren Stahl, Vice President and Head of Partnerships, Healthcare Solutions at Komodo Health, a healthcare software company that has created the industry’s largest and most comprehensive database of anonymized real-patient data. “Through our partnership with DeepIntent, healthcare marketers can run their campaigns with unprecedented speed and accuracy and ultimately improve results.”
DeepIntent Outcomes enables healthcare marketers to:
- Plan and coordinate healthcare provider and direct-to-consumer campaigns based on patient and provider information, including past and present script performance;
- Activate media across channels, including display, video and connected TV, and devices while bidding to improve business results;
- Measure how each campaign performs in real time; and
- To optimise running campaigns by automatically adjusting campaign settings to increase audience quality and scripts while maximizing media effectiveness.
To learn more about DeepIntent Outcomes or to schedule a live DSP demo, visit www.deepintent.com/deepintent-outcomes/.
Designed by former Memorial Sloan Kettering data scientists, DeepIntent connects healthcare companies to patients and providers across all devices through unique data, media partnerships and integrations. From campaign planning and audience targeting to measurement and optimization, DeepIntent has been proven to increase script lift while improving patients’ quality of life. Its healthcare marketing platform empowers marketers from seven of the top ten pharmaceutical companies and leading healthcare advertising agencies to positively influence health and business outcomes. For more information, visit DeepIntent.com or find us on Twitter, FacebookWhere LinkedIn.